{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:18:06Z","timestamp":1790957886815,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-024-02196-y","type":"journal-article","created":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T20:01:37Z","timestamp":1733688097000},"page":"2387-2394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Lentiviral Injection of Inter-\u03b1-Trypsin Inhibitor Heavy Chain 4 Promotes Female Spinal Cord Injury Mice Recuperation by Diminishing Peripheral and Central Inflammation"],"prefix":"10.1007","volume":"48","author":[{"given":"Jiaqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,9]]},"reference":[{"key":"2196_CR1","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/S1474-4422(23)00287-9","volume":"22","author":"GBDSCI Collaborators","year":"2023","unstructured":"Collaborators, G. B. D. S. C. I. 2023. Global, regional, and national burden of spinal cord injury, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurology 22: 1026\u20131047.","journal-title":"Lancet Neurology"},{"key":"2196_CR2","doi-asserted-by":"publisher","first-page":"7533","DOI":"10.3390\/ijms21207533","volume":"21","author":"A Anjum","year":"2020","unstructured":"Anjum, A., M. D. Yazid, M. Fauzi Daud, et al. 2020. Spinal Cord Injury: Pathophysiology, Multimolecular Interactions, and Underlying Recovery Mechanisms. International Journal of Molecular Sciences 21: 7533.","journal-title":"International Journal of Molecular Sciences"},{"key":"2196_CR3","doi-asserted-by":"publisher","first-page":"13833","DOI":"10.3390\/ijms232213833","volume":"23","author":"R Lima","year":"2022","unstructured":"Lima, R., A. Monteiro, A.J. Salgado, et al. 2022. Pathophysiology and Therapeutic Approaches for Spinal Cord Injury. International Journal of Molecular Sciences 23: 13833.","journal-title":"International Journal of Molecular Sciences"},{"key":"2196_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/mmr.2021.12056","volume":"23","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., A. Al Mamun, Y. Yuan, et al. 2021. Acute spinal cord injury: Pathophysiology and pharmacological intervention (Review). Molecular Medicine Reports 23: 1\u201318.","journal-title":"Molecular Medicine Reports"},{"key":"2196_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41392-023-01477-6","volume":"8","author":"X Hu","year":"2023","unstructured":"Hu, X., W. Xu, Y. Ren, et al. 2023. Spinal cord injury: Molecular mechanisms and therapeutic interventions. Signal Transduction and Targeted Therapy 8: 245.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2196_CR6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12974-021-02337-2","volume":"18","author":"DJ Hellenbrand","year":"2021","unstructured":"Hellenbrand, D. J., C. M. Quinn, Z. J. Piper, et al. 2021. Inflammation after spinal cord injury: A review of the critical timeline of signaling cues and cellular infiltration. Journal of Neuroinflammation 18: 284.","journal-title":"Journal of Neuroinflammation"},{"key":"2196_CR7","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.3390\/cells11172692","volume":"11","author":"X Freyermuth-Trujillo","year":"2022","unstructured":"Freyermuth-Trujillo, X., J. J. Segura-Uribe, H. Salgado-Ceballos, et al. 2022. Inflammation: A Target for Treatment in Spinal Cord Injury. Cells 11: 2692.","journal-title":"Cells"},{"key":"2196_CR8","doi-asserted-by":"publisher","first-page":"1432224","DOI":"10.3389\/fmed.2024.1432224","volume":"11","author":"XF Zhang","year":"2024","unstructured":"Zhang, X. F., X. L. Zhang, L. Guo, et al. 2024. The function of the inter-alpha-trypsin inhibitors in the development of disease. Frontiers in Medicine (Lausanne) 11: 1432224.","journal-title":"Frontiers in Medicine (Lausanne)"},{"key":"2196_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1620\/tjem.2022.J116","volume":"259","author":"J Zhang","year":"2023","unstructured":"Zhang, J., J. Hu, and W. Zhao. 2023. Longitudinal Change of Serum Inter-alpha-Trypsin Inhibitor Heavy Chain H4 and its Relation with Inflammation, Disease Recurrence, and Mortality in Acute Ischemic Stroke Patients. Tohoku Journal of Experimental Medicine 259: 221\u2013227.","journal-title":"Tohoku Journal of Experimental Medicine"},{"key":"2196_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117679","volume":"552","author":"H Tian","year":"2024","unstructured":"Tian, H., G. Wang, Q. Zhong, et al. 2024. Usability of serum inter-alpha-trypsin inhibitor heavy chain 4 as a biomarker for assessing severity and predicting functional outcome after human aneurysmal subarachnoid hemorrhage: A prospective observational cohort study at a single institution. Clinica Chimica Acta 552: 117679.","journal-title":"Clinica Chimica Acta"},{"key":"2196_CR11","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2147\/NDT.S433264","volume":"19","author":"HS Shentu","year":"2023","unstructured":"Shentu, H. S., Y. H. Chen, Z. Y. Cheng, et al. 2023. A Prospective Cohort Study of Inter-Alpha-Trypsin Inhibitor Heavy Chain 4 as a Serologic Marker in Relation to Severity and Functional Outcome of Acute Intracerebral Hemorrhage. Neuropsychiatric Disease and Treatment 19: 2363\u20132379.","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"2196_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019247","volume":"6","author":"JM Lubieniecka","year":"2011","unstructured":"Lubieniecka, J. M., F. Streijger, J. H. Lee, et al. 2011. Biomarkers for severity of spinal cord injury in the cerebrospinal fluid of rats. PLoS ONE 6: e19247.","journal-title":"PLoS ONE"},{"key":"2196_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12974-023-02833-7","volume":"20","author":"F Yuan","year":"2023","unstructured":"Yuan, F., W. Peng, Y. Yang, et al. 2023. Endothelial progenitor cell-derived exosomes promote anti-inflammatory macrophages via SOCS3\/JAK2\/STAT3 axis and improve the outcome of spinal cord injury. Journal of Neuroinflammation 20: 156.","journal-title":"Journal of Neuroinflammation"},{"key":"2196_CR14","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.bbi.2020.01.025","volume":"87","author":"Z Qian","year":"2020","unstructured":"Qian, Z., J. Chang, F. Jiang, et al. 2020. Excess administration of miR-340-5p ameliorates spinal cord injury-induced neuroinflammation and apoptosis by modulating the P38-MAPK signaling pathway. Brain, Behavior, and Immunity 87: 531\u2013542.","journal-title":"Brain, Behavior, and Immunity"},{"key":"2196_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1474-4422(24)00038-3","volume":"23","author":"GBDNSD Collaborators","year":"2024","unstructured":"Collaborators, G. B. D. N. S. D. 2024. Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurology 23: 344\u2013381.","journal-title":"Lancet Neurology"},{"key":"2196_CR16","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.cca.2009.01.009","volume":"402","author":"RS Kashyap","year":"2009","unstructured":"Kashyap, R. S., A. R. Nayak, P. S. Deshpande, et al. 2009. Inter-alpha-trypsin inhibitor heavy chain 4 is a novel marker of acute ischemic stroke. Clinica Chimica Acta 402: 160\u2013163.","journal-title":"Clinica Chimica Acta"},{"key":"2196_CR17","doi-asserted-by":"publisher","first-page":"28282","DOI":"10.1016\/S0021-9258(18)46925-6","volume":"269","author":"L Chen","year":"1994","unstructured":"Chen, L., S. J. Mao, L. R. McLean, et al. 1994. Proteins of the inter-alpha-trypsin inhibitor family stabilize the cumulus extracellular matrix through their direct binding with hyaluronic acid. Journal of Biological Chemistry 269: 28282\u201328287.","journal-title":"Journal of Biological Chemistry"},{"key":"2196_CR18","doi-asserted-by":"publisher","first-page":"2952386","DOI":"10.1155\/2018\/2952386","volume":"2018","author":"S Quraishe","year":"2018","unstructured":"Quraishe, S., L. H. Forbes, and M. R. Andrews. 2018. The Extracellular Environment of the CNS: Influence on Plasticity, Sprouting, and Axonal Regeneration after Spinal Cord Injury. Neural Plasticity 2018: 2952386.","journal-title":"Neural Plasticity"},{"key":"2196_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108754","volume":"108","author":"QM Pang","year":"2022","unstructured":"Pang, Q. M., S. Y. Chen, Q. J. Xu, et al. 2022. Effects of astrocytes and microglia on neuroinflammation after spinal cord injury and related immunomodulatory strategies. International Immunopharmacology 108: 108754.","journal-title":"International Immunopharmacology"},{"key":"2196_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.796704","volume":"12","author":"L Xu","year":"2021","unstructured":"Xu, L., J. Wang, Y. Ding, et al. 2021. Current Knowledge of Microglia in Traumatic Spinal Cord Injury. Frontiers in Neurology 12: 796704.","journal-title":"Frontiers in Neurology"},{"key":"2196_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.2217\/bmm-2022-0673","volume":"16","author":"Y Huo","year":"2022","unstructured":"Huo, Y., Y. Lai, Q. Feng, et al. 2022. Serum ITIH4 in coronary heart disease: A potential anti-inflammatory biomarker related to stenosis degree and risk of major adverse cardiovascular events. Biomarkers in Medicine 16: 1279\u20131288.","journal-title":"Biomarkers in Medicine"},{"key":"2196_CR22","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1080\/00365513.2023.2250986","volume":"83","author":"Z Sun","year":"2023","unstructured":"Sun, Z., Y. Zhang, H. Zhou, et al. 2023. Serum interalpha-trypsin inhibitor heavy chain H4 may be an anti-inflammatory marker reflecting disease risk, activity and treatment outcome of ankylosing spondylitis. Scandinavian Journal of Clinical and Laboratory Investigation 83: 540\u2013547.","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"2196_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24231","volume":"36","author":"K He","year":"2022","unstructured":"He, K., S. He, and M. Su. 2022. Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis. Journal of Clinical Laboratory Analysis 36: e24231.","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"2196_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","volume":"5","author":"H Yu","year":"2020","unstructured":"Yu, H., L. Lin, Z. Zhang, et al. 2020. Targeting NF-kappaB pathway for the therapy of diseases: Mechanism and clinical study. Signal Transduction and Targeted Therapy 5: 209.","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"2196_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116938","volume":"176","author":"Y Ding","year":"2024","unstructured":"Ding, Y., and Q. Chen. 2024. Recent advances on signaling pathways and their inhibitors in spinal cord injury. Biomedicine & Pharmacotherapy 176: 116938.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2196_CR26","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1007\/s12035-023-03411-x","volume":"60","author":"Y Ding","year":"2023","unstructured":"Ding, Y., and Q. Chen. 2023. The NF-kappaB Pathway: a Focus on Inflammatory Responses in Spinal Cord Injury. Molecular Neurobiology 60: 5292\u20135308.","journal-title":"Molecular Neurobiology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-024-02196-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-024-02196-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T01:28:17Z","timestamp":1757122097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-024-02196-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,9]]},"references-count":26,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["2196"],"URL":"https:\/\/doi.org\/10.1007\/s10753-024-02196-y","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,9]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were approved by the Animal Use Committee and followed the guidelines of our institution.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}